CC
Catalio Capital Management, LP
NEW YORK NY · SEC CIK 0001958125
$532.10M2026Q2 reported value
39Positions
56.7%Top 10 weight · largest 10.4%
3 / 12New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
GILD Added+$13.32M
PTGX New+$13.09M
AXSM New+$10.57M
SEPN Added+$8.10M
FDMT New+$6.27M
2026Q2 top sells estimated at quarter-end value
DNTH Reduced-$51.41M
ASND Reduced-$25.97M
DFTX Reduced-$22.36M
TERNS PHARMACEUT Sold out-$21.56M
SOLENO THERAPEUT Sold out-$19.35M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| AVLN | AVALYN PHARMACEUTICALS INC | $55.17M | 10.37% | 1,675,830 | 1,675,830 | — | — | First reported |
| JNJ | JOHNSON & JOHNSON | $35.29M | 6.63% | 138,946 | 18,106 | 15.0% | $4.60M | Reappeared |
| GILD | GILEAD SCIENCES INC | $34.02M | 6.39% | 269,309 | 105,404 | 64.3% | $13.32M | Added |
| BBIO | BRIDGEBIO PHARMA INC | $33.89M | 6.37% | 455,041 | 23,027 | 5.3% | $1.72M | Added |
| SNDX | SYNDAX PHARMACEUTICALS INC | $26.58M | 4.99% | 1,215,698 | 172,028 | 16.5% | $3.76M | Added |
| DFTX | DEFINIUM THERAPEUTICS INC | $26.47M | 4.97% | 562,672 | -475,312 | -45.8% | -$22.36M | Reduced |
| BMY | BRISTOL-MYERS SQUIBB CO | $23.79M | 4.47% | 412,961 | -7,766 | -1.8% | -$447,477 | Reduced |
| PBLS | PARABILIS MEDICINES INC | $22.55M | 4.24% | 824,043 | 824,043 | — | — | First reported |
| NTRA | NATERA INC | $22.31M | 4.19% | 82,181 | 11,274 | 15.9% | $3.06M | Added |
| INCY | INCYTE CORP | $21.72M | 4.08% | 191,627 | 9,526 | 5.2% | $1.08M | Added |
| SEPN | SEPTERNA INC | $17.96M | 3.37% | 536,152 | 241,792 | 82.1% | $8.10M | Added |
| MLYS | MINERALYS THERAPEUTICS INC | $17.50M | 3.29% | 648,722 | 209,681 | 47.8% | $5.66M | Added |
| HTFL | HEARTFLOW INC | $17.11M | 3.21% | 583,055 | 179,467 | 44.5% | $5.27M | Added |
| CRVS | CORVUS PHARMACEUTICALS INC | $16.15M | 3.03% | 1,080,888 | 188,955 | 21.2% | $2.82M | Added |
| GPCR | STRUCTURE THERAPEUTICS INC | $14.84M | 2.79% | 276,550 | 21,171 | 8.3% | $1.14M | Added |
| PTGX | PROTAGONIST THERAPEUTICS INC | $13.09M | 2.46% | 106,799 | 106,799 | — | $13.09M | New |
| IRON | DISC MEDICINE INC | $11.66M | 2.19% | 159,384 | 36,406 | 29.6% | $2.66M | Added |
| EW | EDWARDS LIFESCIENCES CORP | $11.29M | 2.12% | 124,778 | -19,829 | -13.7% | -$1.79M | Reduced |
| AXSM | AXSOME THERAPEUTICS INC. | $10.57M | 1.99% | 43,182 | 43,182 | — | $10.57M | New |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $10.56M | 1.98% | 316,252 | -534,545 | -62.8% | -$17.85M | Reduced |
| KLRA | KAILERA THERAPEUTICS INC | $10.33M | 1.94% | 468,750 | 468,750 | — | — | First reported |
| KPTI | KARYOPHARM THERAPEUTICS INC | $9.19M | 1.73% | 940,855 | 43,146 | 4.8% | $421,536 | Added |
| ODTX | ODYSSEY THERAPEUTICS INC | $8.57M | 1.61% | 457,839 | 457,839 | — | — | First reported |
| ASND | ASCENDIS PHARMA A/S | $8.47M | 1.59% | 31,759 | -97,352 | -75.4% | -$25.97M | Reduced |
| KARD | KARDIGAN INC | $7.45M | 1.40% | 312,500 | 312,500 | — | — | First reported |
| ELDN | ELEDON PHARMACEUTICALS INC | $6.68M | 1.26% | 1,695,071 | 55,255 | 3.4% | $217,705 | Added |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $6.27M | 1.18% | 471,254 | 471,254 | — | $6.27M | New |
| MANE | VERADERMICS INC | $5.64M | 1.06% | 45,856 | -127,726 | -73.6% | -$15.70M | Reduced |
| DYN | DYNE THERAPEUTICS INC | $5.44M | 1.02% | 244,929 | -38,025 | -13.4% | -$844,535 | Reduced |
| — | FRACTYL HEALTH INC | $4.90M | 0.92% | 6,168,749 | 676,883 | 12.3% | $537,716 | Added |
| IMCR | IMMUNOCORE HLDGS PLC | $4.70M | 0.88% | 148,045 | 63,693 | 75.5% | $2.02M | Added |
| DNTH | DIANTHUS THERAPEUTICS INC | $3.21M | 0.60% | 32,941 | -527,367 | -94.1% | -$51.41M | Reduced |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $2.43M | 0.46% | 318,407 | -92,293 | -22.5% | -$703,273 | Reappeared |
| TARA | PROTARA THERAPEUTICS INC | $1.99M | 0.37% | 520,148 | -59,876 | -10.3% | -$228,726 | Reduced |
| — | HYPERFINE INC | $1.78M | 0.33% | 1,320,041 | 0 | 0.0% | — | Unchanged |
| — | ATAIBECKLEY INC | $1.04M | 0.19% | 196,858 | 0 | 0.0% | — | Unchanged |
| — | METAGENOMI THERAPEUTICS INC | $629,502 | 0.12% | 528,993 | 0 | 0.0% | — | Unchanged |
| — | OUTSET MED INC | $510,965 | 0.10% | 118,279 | 0 | 0.0% | — | Unchanged |
| FTH | FAETH THERAPEUTICS INC | $367,950 | 0.07% | 14,718 | 0 | 0.0% | — | Unchanged |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -409,031 | -100.0% | -$21.56M | Sold out |
| — | SOLENO THERAPEUTICS INC | $0 | 0.00% | 0 | -577,808 | -100.0% | -$19.35M | Sold out |
| BSX | BOSTON SCIENTIFIC CORP | $0 | 0.00% | 0 | -299,318 | -100.0% | -$18.78M | Sold out |
| CYTK | CYTOKINETICS INC | $0 | 0.00% | 0 | -215,501 | -100.0% | -$14.20M | Sold out |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $0 | 0.00% | 0 | -722,784 | -100.0% | -$10.03M | Sold out |
| — | KALVISTA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -426,551 | -100.0% | -$8.59M | Sold out |
| QURE | UNIQURE NV | $0 | 0.00% | 0 | -491,116 | -100.0% | -$8.03M | Sold out |
| ABVX | ABIVAX SA | $0 | 0.00% | 0 | -47,193 | -100.0% | -$5.25M | Sold out |
| — | SUPERNUS PHARMACEUTICALS | $0 | 0.00% | 0 | -62,019 | -100.0% | -$3.21M | Sold out |
| PHAT | PHATHOM PHARMACEUTICALS INC | $0 | 0.00% | 0 | -247,767 | -100.0% | -$2.75M | Sold out |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | $0 | 0.00% | 0 | -83,554 | -100.0% | -$2.67M | Sold out |
| TYRA | TYRA BIOSCIENCES INC | $0 | 0.00% | 0 | -67,285 | -100.0% | -$2.58M | Sold out |